The present invention discloses novel compounds of Formula I: ( I ) possessing11β-HSD type 1 antagonist activity, as well as methods for preparing suchcompounds. In another embodiment, the invention discloses pharmaceuticalcompositions comprising compounds of Formula I, as well as methods of using thecompounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension,hyperlipidemia, metabolic syndrome, cognitive disorders, and other conditionsassociated with 11β-HSD type 1 activity.